LIVN

LivaNova PLC Ordinary Shares

64.03

USD

LIVN Earnings Reports

Positive Surprise Ratio

LIVN beat 33 of 40 last estimates.

83%

Next Report

Date of Next Report

May 05, 2026

Estimate for Q1 26 (Revenue/ EPS)

$352.42M

$0.90

Implied change from Q4 25 (Revenue/ EPS)

-2.35%

+4.65%

Implied change from Q1 25 (Revenue/ EPS)

+11.21%

+2.27%

LivaNova PLC Ordinary Shares earnings per share and revenue

On Feb 25, 2026, LIVN reported earnings of 0.86 USD per share (EPS) for Q4 25, beating the estimate of 0.83 USD, resulting in a 3.44% surprise. Revenue reached 360.90 million, compared to an expected 360.38 million, with a 0.14% difference. The market reacted with a +1.80% price change (close before vs. close after earnings).

Looking ahead to Q1 26, 10 analysts forecast an EPS of 0.90 USD, with revenue projected to reach 352.42 million USD, implying an increase of 4.65% EPS, and decrease of -2.35% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Alpha Tau Medical Ltd. Ordinary Shares

Report Date

Mar 09, 2026 For Q4 25

Estimate

-$0.12

Actual

-$0.08

Surprise

+36.51%

ClearPoint Neuro, Inc. Common Stock

Report Date

Mar 17, 2026 For Q4 25

Estimate

-$0.20

Actual

-$0.27

Surprise

-32.35%

Stereotaxis, Inc. Common Stock

Report Date

Mar 09, 2026 For Q4 25

Estimate

-$0.06

Actual

-$0.06

Surprise

+10.04%

Rapid Micro Biosystems, Inc. Class A Common Stock

Report Date

Mar 12, 2026 For Q4 25

Estimate

-$0.22

Actual

-$0.28

Surprise

-23.35%

Hyperfine, Inc. Class A Common Stock

Report Date

Mar 18, 2026 For Q4 25

Estimate

-$0.08

Actual

-$0.08

Surprise

+1.96%

Neuronetics, Inc. Common Stock

Report Date

Mar 17, 2026 For Q4 25

Estimate

-$0.10

Actual

-$0.10

Surprise

+8.09%

InspireMD, Inc.

Report Date

Mar 18, 2026 For Q4 25

Estimate

-$0.19

Actual

-$0.14

Surprise

+29.01%

Nuwellis, Inc. Common Stock

Report Date

Mar 10, 2026 For Q4 25

Estimate

-$1.59

Actual

-$1.50

Surprise

+5.73%

FAQ

What were LivaNova PLC Ordinary Shares's earnings and revenue for the latest quarter Q4 2025?

For Q4 2025, LivaNova PLC Ordinary Shares reported EPS of $0.86, beating estimates by 3.44%, and revenue of $360.90M, 0.14% above expectations.

How did the market react to LivaNova PLC Ordinary Shares's Q4 2025 earnings?

The stock price moved up 1.8%, changed from $69.05 before the earnings release to $70.29 the day after.

When is LivaNova PLC Ordinary Shares expected to report next?

The next earning report is scheduled for May 05, 2026.

What are the forecasts for LivaNova PLC Ordinary Shares's next earnings report?

Based on 10 analysts, LivaNova PLC Ordinary Shares is expected to report EPS of $0.90 and revenue of $352.42M for Q1 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.